Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions.
about
Endoscopic therapies are ever-changing strategies and neverending challenges for gastroenterological neoplasia and the refractory conditions.Silencing of Carbohydrate Sulfotransferase 15 Hinders Murine Pulmonary Fibrosis Development.New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease.Immunological pathogenesis of inflammatory bowel disease.
P2860
Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@en
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@nl
type
label
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@en
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@nl
prefLabel
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@en
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@nl
P2093
P2860
P356
P1476
Phase 1 Clinical Study of siRN ...... s with Active Mucosal Lesions.
@en
P2093
Hiroki Sato
Hiroyuki Yoneyama
Hitoshi Asakura
Junji Yokoyama
Kazuichi Okazaki
Kazuyuki Sugahara
Kenichi Watanabe
Kenji Suzuki
Markus F Neurath
Raja Atreya
P2860
P304
P356
10.1093/ECCO-JCC/JJW143
P577
2016-08-01T00:00:00Z